Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Thousands Protest over Lockdown, Vaccine Passports

Protesters gathered in London to take a stand against the…
Read more

China’s ‘breathtaking’ nuclear expansion

China is in the process of expanding their nuclear forces…
Read more

SCOTUS Takes Up NRA-Backed Gun Rights Case

The Supreme Court has decided to take on the big case of…
Read more